Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
Admitted local publications that cite Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study.